6-K
Alterity Therapeutics Ltd (ATHE)
SECURITIESAND EXCHANGE COMMISSION
Washington,D.C. 20549
FORM6-K
REPORTOF FOREIGN PRIVATE ISSUER
PURSUANTTO RULE 13a-16 OR 15d-163
UNDERTHE SECURITIES EXCHANGE ACT OF 1934
Forthe month of July 2025
AlterityTherapeutics Limited
(Name of Registrant)
Level 14, 350 Collins Street,Melbourne, Victoria 3000 Australia
(Address of Principal Executive Office)
Indicateby check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
ThisForm 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980and 333-228671) and ourRegistration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417and 333-250076)
ALTERITYTHERAPEUTICS LIMITED
(adevelopment stage enterprise)
The following exhibits are submitted:
| 99.1 | Application for quotation of securities - ATH |
|---|
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Alterity Therapeutics Limited | |
|---|---|
| By: | /s/ Geoffrey P. Kempler |
| Geoffrey P. Kempler | |
| Chairman |
Date: July 17, 2025
2
Exhibit 99.1
| Appendix<br> 2A - Application for quotation of securities |
|---|
Announcement Summary
Entity name
ALTERITY THERAPEUTICS LIMITED
Announcement Type
New announcement
Date of this announcement
Thursday July 17, 2025
The +securities to be quoted are:
+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted
Total number of +securities to be quoted
| ASX +security code | Security description | Number of +securities to be quoted | Issue date |
|---|---|---|---|
| ATH | ORDINARY<br> FULLY PAID | 79,999,800 | 17/07/2025 |
Refer to next page for full details of the announcement
| Appendix 2A - Application for quotation of securities | 1 / 6 |
| --- | --- | | Appendix<br> 2A - Application for quotation of securities | | --- |
Part 1 - Entity and announcement details
1.1Name of entity
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
| 1.2 Registered number type | Registration number |
|---|---|
| ABN | 37080699065 |
1.3ASX issuer code
ATH
1.4The announcement is
New announcement
1.5Date of this announcement
17/7/2025
| Appendix 2A - Application for quotation of securities | 2 / 6 |
| --- | --- | | Appendix<br> 2A - Application for quotation of securities | | --- |
Part 2 - Type of Issue
2.1The +securities to be quoted are:
+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted
2.2 The +class of +securities to be quoted is:
Additional +securities in a class that is already quoted on ASX (“existing class”)
| Appendix 2A - Application for quotation of securities | 3 / 6 |
| --- | --- | | Appendix<br> 2A - Application for quotation of securities | | --- |
Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an
Appendix 3B
Existing +securities converting into additional +securities in an existing class
FROM (Existing Class)
ASX +security code and description
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003
TO (Existing Class)
ASX +security code and description
ATH : ORDINARY FULLY PAID
| Please state the number of options that were exercised or other +convertible securities that were converted | The first date the options were exercised or other +convertible securities were converted | The last date the options were exercised or other +convertible securities were converted |
|---|---|---|
| 79,999,800 | 17/7/2025 |
Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)?
No
Theright of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:
An issue of new +securities
Theunderlying +securities being received by the holder are:
Intended to be, but are not yet, quoted by ASX ****
Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme?
Yes
Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate?
Yes
Provide details of the KMP or +associates who are exercising options or converting convertible securities
| Name of KMP | Name of registered holder | Number of options being exercised or other +convertible securities being converted |
|---|---|---|
| David Stamler | David Stamler | 79,999,800 |
Issue date
17/7/2025
Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?
Yes
| Appendix 2A - Application for quotation of securities | 4 / 6 |
| --- | --- | | Appendix<br> 2A - Application for quotation of securities | | --- |
Issue details
Numberof +securities to be quoted
79,999,800
Arethe +securities being issued for a cash consideration?
Yes
| In what currency is the cash consideration being paid? | What is the issue price per +security? |
|---|---|
| USD - US Dollar | USD 0.00300000 |
Anyother information the entity wishes to provide about the +securities to be quoted
| Appendix 2A - Application for quotation of securities | 5 / 6 |
| --- | --- | | Appendix<br> 2A - Application for quotation of securities | | --- |
Part 4 - Issued capital following quotation
Followingthe quotation of the +securities the subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity’s current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of thisapplication)
| ASX +security code and description | Total<br> number of<br><br> +securities on issue |
|---|---|
| ATH : ORDINARY FULLY PAID | 9,207,370,486 |
| ATHO : OPTION EXPIRING 31-AUG-2026 | 932,611,269 |
| ATHOA : OPTION EXPIRING 26-FEB-2027 | 1,222,300,911 |
4.2Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
| ASX +security code and description | Total number of +securities on issue |
|---|---|
| ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 | 10,000,000 |
| ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 | 11,500,000 |
| ATHAD : OPTION EXPIRING 01-JUL-2030 EX $0.01 | 15,000,000 |
| ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 | 35,000,000 |
| ATHAAK : OPTION EXPIRING 30-DEC-2027 EX $0.01 | 170,000,000 |
| ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 | 8,000,000 |
| ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031 | 62,500,000 |
| ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004 | 20,166,667 |
| ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003 | 40,000,200 |
| ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 | 91,392,720 |
| Appendix 2A - Application for quotation of securities | 6 / 6 |
| --- | --- |